Image

Global Wearable Injectors Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Wearable Injectors Market By Type (On-Body, Off-Body (Infusion Pump Devices)), By Therapy (Immuno-Oncology, Diabetes, Cardiovascular Diseases, Parkinson's Disease, Thalassemia, Primary Immunodeficiency Disease), By Technology (Spring-based, Motor-driven), By End-Use (Hospitals, Clinics, Homecare, Others); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis – Industry Trends and Forecast to 2029

Wearable Injectors Market

Market Analysis and Size

The market is growing due to the rising frequency of chronic medical conditions such as oncological, neurological, and autoimmune disorders. Furthermore, the growing senior population, which is more susceptible to such illnesses, and the growing demand for minimally invasive (MI) treatment options among patients are propelling the market forward. There is also a rising preference for at-home and self-administrable injectors to efficiently manage illnesses with negligible risks of inaccurate dosage and needle stick injuries. 

Data Bridge Market Research analyses that the wearable injectors market, which was USD 6.0 billion in 2021, would rocket up to USD 12.54 billion by 2029 and is expected to undergo a CAGR of 9.65% during the forecast period. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Wearable injectors, or patch pumps, are compacted drug delivery devices used for single-step administration of drugs to lengthier extents. They are temporarily applied to the skin in order to deliver large amounts of sticky medications via the body's subcutaneous tissues more quickly and safely. They're frequently available with both on-body and off-body injectors. The device is made up of a reservoir for storing medicine, a cannula for delivering material to tissues, and a driving system for delivering the right amount of medicines.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

By Type (On-Body, Off-Body (Infusion Pump Devices), By Therapy (Immuno-Oncology, Diabetes, Cardiovascular Diseases, Parkinson's Disease, Thalassemia, Primary Immunodeficiency Disease), By Technology (Spring-based, Motor-driven), By End-Use (Hospitals, Clinics, Homecare, Others); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

BD (U.S), Ypsomed (Switzerland), Amgen Inc. (U.S), Subcuject Aps (Denmark), Enable Injections (U.S), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (U.S), CeQur SA (Switzerland), Sensile-medical (Switzerland), SteadyMed Therapeutics (U.S), ATS Automation (Canada), West Pharmaceutical Services, Inc. (U.S), Unilife Corporation (U.K), Tandem Diabetes Care (US), Valeritas (U.S), Bühler Motor GmbH (Switzerland), Sonceboz (Switzerland), Noble (U.S), Elcam Drug Delivery Devices (Israel), Bespak Europe Ltd. (U.K), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland), and Neuma (U.S)

Market Opportunities

  • Increasing quantity of biologics in the drug development
  • Growing number of biologics in the drug development pipeline

Wearable Injectors Market Dynamics

Drivers

  • Growing number of biologics in the drug development pipeline

 In most cases, biologics are inoculated by intravenous infusion in the hospital. Self-administration in the home has been increasingly popular during the last decade. Libertas, a product from BD, is now being utilised to administer several biologic medications in research, giving the company a foothold in the CRO market.

Cost and complications linked with the traditional settings

Patients to switch towards more cost-effective alternatives, generating demand for wearable injectors. Moreover, wearable injectors offer recompenses such as ease of management, reduced pain, and minimalized hassle associated with syringes, thereby increasing market growth.

Opportunities

Moreover, an upsurge in the public-private funding for target research activities, rising demand for minimally invasive surgeries, the growing participation of youngsters in sports, and increasing product novelties and development owed to technical advancements all around the world will extend profitable occasions for the market players in the forecast period of 2022 to 2029. Additionally, rising internet penetration rate, increasing adoption of arthroscopic surgeries, rise in the elderly and obese population globally and rising per capita expenditure on health care will further expand the market's growth rate.

Restraints/Challenges

  • Patient noncompliance with prescribed pharmaceutical therapy

Patients have been pushed to change to more cost-effective options because of the expenses and complications connected with conservative setups, resulting in a preference for such injectors. When linked to syringes, these injectors provide aids, including simplicity of delivery, pain control, and reduced inopportuneness, all of which donate to market growth.

  • Presence and demand for substitute drug delivery mechanisms

Besides, an unfavorable reimbursement environment, particularly in emerging countries, is likely to restrain the global market's growth throughout the forecast period. Since biologics and mAbs must be delivered through the parenteral route, an increasing emphasis on their usage to cure infections comparable to rheumatoid arthritis, cardiovascular disease, and cancer will create a surge in the wearable injectors market chances existing globally.

  • Unfavorable reimbursement structure in evolving countries

Many developing countries do not offer compensation for injectors that can be worn. Wearable insulin pumps, for example, are not reimbursed in India, and no explicit guidelines for their use are provided in training. In China, patients with Type 1 diabetes must pay for their insulin pumps and supplies out of pocket. The lack of reimbursement directly disturbs access to and the adoption of wearable injectors and is thus expected to affect the market's growth in the upcoming years harmfully.

This wearable injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the wearable injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Wearable Injectors Market

The threat of receiving exposure to COVID-19 has urged patients, especially those suffering from chronic diseases, to choose self-administration of medication at home. Healthcare earners also keep healthcare resources free for acute care or COVID-19 infected patients. As a result, demand for remote care technology such as wearable injectors has grown. As a result, despite the COVID-19 epidemic, the market for wearable injectors is expected to grow steadily and optimistically during this time.

Recent Development

  • In 2019, Enable Injections and Sanofi announced a collaboration for the enFuse drug delivery platform. enFuse is a self-contained drug delivery stage that can be used with normal nozzles or vial vessel shapes. On the basis of type, the market is divided into on-body and off-body wearable injectors.
  • In June 2020, Insulet Corporation, a global leader in tubeless insulin pump technology with its Omnipod Insulin Management System, prolonged its financial help program for its customers in the U.S., who were harmfully wedged by the COVID-19 pandemic. Below the program, the customer may gain up to a six-month supply of products (60 Pods) free of charge.

Global Wearable Injectors Market Scope

The wearable injectors market is segmented on the basis of type, price range, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type 

  • On-body
  • Off-body

On the basis of type the market is segmented into on-body and off-body.

Technology

  • Spring-based
  • Motor-driven
  • Rotary Pump
  • Expanding Battery
  • Other

On the basis of technology the market is segmented into spring-based, motor-driven, rotary pump, expanding battery and other.

Application

On the basis of application the market is segmented into oncology, infectious diseases, cardiovascular diseases, autoimmune diseases and others.

End-user

  • Hospitals
  • Clinics
  • Home Care
  • Others

On the basis of end-user the market is segmented into hospitals, clinics, home care and others.

 Wearable Injectors Market Regional Analysis/Insights

The wearable injectors market is analyzed and market size insights and trends are provided by country, type, price range, application and end-user as referenced above.

The countries covered in the wearable injectors market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the market in 2020 with a 41.5 percent share Because of the increased frequency of chronic and lifestyle-related disorders, as well as sophisticated healthcare infrastructure.

Over the forecast period, Asia-Pacific is expected to be the fastest-growing regional market. This can be linked to an expanding senior population, particularly in Japan, as well as a large diabetes population in China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Healthcare Infrastructure growth Installed base and New Technology Penetration

The wearable injectors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for wearable injectors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the wearable injectors market. The data is available for historic period 2010-2020.

Competitive Landscape and Wearable Injectors Market Share Analysis

The wearable injectors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to wearable injectors market.

Some of the major players operating in the wearable injectors market are:

  • BD (U.S)
  • Ypsomed (Switzerland),
  • Amgen Inc.(US)
  • Subcuject Aps (Denmark)
  • Enable Injections (U.S)
  • Medtronic plc (Ireland)
  • Insulet Corporation (US)
  • United Therapeutics Corp. (U.S)
  • CeQur SA (Switzerland)
  • Sensile-medical (Switzerland)
  • SteadyMed Therapeutics (U.S)
  • ATS Automation (Canada)
  • West Pharmaceutical Services, Inc. (U.S)
  • Unilife Corporation (U.K)
  • Tandem Diabetes Care (U.S)
  • Valeritas (U.S)
  • Bühler Motor GmbH (Switzerland)
  • Sonceboz (Switzerland)
  • Noble (U.S)
  • Elcam Drug Delivery Devices (Israel)
  • Bespak Europe Ltd. (U.K)
  • Stevanato Group (Italy)
  •  Sorrel Medical (Israel)
  • Weibel CDS AG (Switzerland)
  •  Neuma (U.S)

Research Methodology: Global Wearable Injectors Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Wearable Injectors Market value is expected USD 12.54 billion by 2029.
The Wearable Injectors Market is projected to grow at a CAGR of 9.65% during the forecast period of 2022-2029.
On the basis of Technology , the Wearable Injectors Market is segmented into Spring-based, Motor-driven), By End-Use (Hospitals, Clinics, Homecare, Others.
The major countries covered in the Wearable Injectors Market BD (U.S), Ypsomed (Switzerland), Amgen Inc. (U.S), Subcuject Aps (Denmark), Enable Injections (U.S), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (U.S), CeQur SA (Switzerland), Sensile-medical (Switzerland), SteadyMed Therapeutics (U.S), ATS Automation (Canada), West Pharmaceutical Services, Inc. (U.S), Unilife Corporation (U.K), Tandem Diabetes Care (US), Valeritas (U.S), Bühler Motor GmbH (Switzerland), Sonceboz (Switzerland), Noble (U.S), Elcam Drug Delivery Devices (Israel), Bespak Europe Ltd. (U.K), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland), and Neuma (U.S).